Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A computational method to design broad-spectrum T cell-inducing vaccines applied to Betacoronaviruses.

Cell reports methods·2026
Same author

The Establishment of an Indigenous-Led Drinking Water Monitoring Program Leveraging qPCR and Metagenomics Testing in New Zealand.

Water environment research : a research publication of the Water Environment Federation·2026
Same author

Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency Response.

Vaccines·2026
Same author

Progress and prospects for herpesvirus vaccination using gB antigens.

Frontiers in immunology·2026
Same author

Cruise-ship hantavirus cluster exposes a wider preparedness gap.

Nature·2026
Same author

Intranasal boosting enhances genital tract T cell immunity following ChAdOx1/MVA hrHPV therapeutic vaccination.

NPJ vaccines·2026

相关实验视频

Updated: Jun 10, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.0K

狂犬病糖蛋白工程用于改善稳定性和表达.

Solomon English1, Sofiya Fedosyuk1, Francisco Orliacq1

  • 1Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom.

Vaccine
|July 27, 2025
PubMed
概括
此摘要是机器生成的。

开发新的狂犬病疫苗对于可访问性至关重要. 研究人员对狂犬病病毒糖蛋白 (RVG) 进行了改造,以提高疫苗免疫性,但发现野生型RVG足以用于小鼠当前的mRNA和腺病毒平台.

关键词:
亚地诺病毒是亚地诺病毒.狂犬病病毒的葡萄糖蛋白是狂犬病病毒的糖蛋白.结构导向设计是指导结构的设计.亚单位疫苗 亚单位疫苗它们是mRNARNA.

更多相关视频

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

12.8K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.3K

相关实验视频

Last Updated: Jun 10, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.0K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

12.8K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.3K

科学领域:

  • 疫苗学 疫苗学 疫苗学
  • 分子生物学分子生物学
  • 免疫学 免疫学 免疫学

背景情况:

  • 目前的狂犬病疫苗很昂贵,需要多剂量,限制了全球的使用.
  • 开发新型,低成本的疫苗,引起对狂犬病病毒糖蛋白 (RVG) 的强有力的免疫反应,是优先事项.

研究的目的:

  • 研究结构引导的抗原工程和转基因磁带优化,以提高狂犬病疫苗免疫性.
  • 评估针对狂犬病病毒增强表达,稳定性和保护性抗体反应的新型疫苗结构.

主要方法:

  • 评估了12个候选转基因磁带设计,包括代优化和共同表达策略.
  • 在低pH下选了72个RVG突变结构以检测体外表达和融合前稳定性.
  • 在小鼠中使用mRNA疫苗平台测试野生型RVG和突变构造物的免疫性.

主要成果:

  • 子优化改善了体外表达,但没有提高免疫性.
  • 突变结构表现出增强的表达和/或稳定性,特定的双重突变 (L271Q + H419L) 显示出最大的表达增加.
  • 与mRNA疫苗中的野生型RVG相比,无论是工程RVG突变还是磁带优化都没有提高免疫性.

结论:

  • 虽然某些突变增强了RVG表达和稳定性,但它们并没有转化为mRNA疫苗中免疫性改善.
  • 全长野生型RVG似乎足够稳定,并在腺病毒和mRNA狂犬病疫苗中表达出最佳免疫性.
  • 工程化RVG突变可能对未来的蛋白质子单元疫苗开发有潜力.